Antacid Medications Market Growth Opportunities in Grooming Regions 2026 By Key Players Pfizer Inc, GlaxoSmithKline plc, Dabur India Limited, Abbott Laboratories
Get PDF Brochure of Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/91
Increasing incidence of acid reflux in North America fueling growth of the antacid medications market
Increasing trend of self-medication consequently fuels demand for OTC digestive products for treatment of gastrointestinal distress. Antacids are used to neutralize acidity and thus, are expected to lead to rampant increase in demand for the same in North America due to rising incidence of gastroesophageal reflux disease (GERD) in the region. According to a study conducted by American Gastroenterological Association and published in International Foundation for Functional in February 2016, approximately one-third of the population in U.S. suffers from GERD. According to a study published in National Center for Biotechnology Information (NCBI) in June 2014, the range of GERD prevalence was 18.1%–27.8% in North America, 8.7%–33.1% in the Middle East, 8.8%–25.9% in Europe, 2.5%–7.8% in East Asia, and 11.6% in Australia. Increasing prevalence of GERD creates a favorable environment growth of the antacid medications market.
Increasing self-medication trend driving antacid medications market growth
Increasing inclination of the populace towards self-medication supplemented by growing availability of over-the-counter products in convenient to use sachets is a prevalent trend observed in the market. This trend is expected to continue over the forecast period, in turn fueling market growth.
Global players operating in the antacid medications market
Various companies manufacture antacids and other products for indigestion. Some of these are GlaxoSmithKline plc, Dabur India Limited, Abbott Laboratories, and Pfizer, Inc. Sun Pharma launched an ayurvedic digestive remedy called Pepmelt to compete with popular antacids such as Eno (GSK consumer healthcare), Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer). According to 2014 estimates of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 20% of the U.S. population suffered from gastroesophageal reflux disease, or GERD.
Request For Customization Of This Report : https://www.coherentmarketinsights.com/insight/request-customization/91
Antacid medications market taxonomy – Formulation, Drug and Demographic
Antacid medications market is classified by various ways such as by formulation, drug and Demographic. On the basis of formulation, the antacid medications market is classified as tablets, capsules, suspensions, and drops. On the basis of demographic, antacid medications market is classified as products for pediatrics and products for adults. On the basis of drug, antacid medications market is classified as histamine-2 (H2) blockers, proton pump inhibitor, and pro-motility agents. Examples of H2 blocker include Nizatidine, Ranitidine, Cimetidine, and famotidine. Proton pump inhibitors used for acid reflux include Rabeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Omeprazole. Pro-motility agents stimulate the muscles of gastrointestinal tract and strengthen lower esophageal sphincter, and reduce reflux into esophagus. Metoclopramide is used to treat heartburn associated with GERD.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antacid Medications Market Growth Opportunities in Grooming Regions 2026 By Key Players Pfizer Inc, GlaxoSmithKline plc, Dabur India Limited, Abbott Laboratories here
News-ID: 1329580 • Views: 644
More Releases from Coherent Market Insights - Pharmaceutical Industry
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around
More Releases for GERD
South Korea GERD Market to Witness Huge Growth by 2019-2028
The South Korea GERD market for the forecasting period of 2019-2028. The report is made out with a comprehensive analysis of the current market and pulled down the key factors that propel the growth of the South Korea GERD market in the forecasted period. This report also encompasses key market drivers and the hindering restraints of the South Korea GERD market. Complete summary of this research report @ https://insights10.com/product/south-korea-gerd-market-analysis/ This report on
Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023
WiseGuyReports.Com Publish a New Market Research Report On –“ Gerd & Nerd Treatment Industry – Treatment Analysis,Research,Review to 2023”. Gerd & Nerd TreatmIndustry 2019 Description:- In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry. The Gastroesophageal Reflux
GERD Market– A Comprehensive Study with Key Players: AstraZeneca, Eisai, Glaxo …
HTF MI recently introduced Global GERD Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AstraZeneca, Eisai, GlaxoSmithKline, Johnson & Johnson & Takeda etc. Request Sample of
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market - Trends, Outloo …
Gastroesophageal refers to the stomach and esophagus. Reflux means to return or flow back. Gastroesophageal reflux disease or GERD is a set of conditions, where the lower esophageal sphincter (LES) is affected when the contents of the stomach flows back to the esophagus. In usual digestion process, the lower esophageal sphincter unfastens to let food to pass into stomach and shuts to prevent acidic stomach juices and food from going
GERD Drugs and Devices Market: Emerging niche segments and regional markets
Through the esophagus, food enters the stomach and mixes with gastric acid, enzymes, and other gastric juices for digestion purpose. The ring-like muscle at the junction of the esophagus and the stomach, known as lower esophageal sphincter (LES), controls the flow of food from the esophagus to the stomach and does not allow backflow of gastric fluids into the esophagus. Gastroesophageal reflux disease (GERD) is a condition where the LES